Newer biomarkers in heart failure.

Gupta S; Drazner MH; de Lemos JA

首页> 外文期刊>Heart failure clinics >Newer biomarkers in heart failure.

【24h】

Newer biomarkers in heart failure.

机译：心力衰竭的新型生物标志物。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The pathophysiology of heart failure is complex, and the list of biomarkers representing distinct pathophysiologic pathways is growing rapidly. This article focuses on some promising newer biomarkers that have contributed to a better understanding of pathophysiologic mechanisms involved in heart failure but for which less data are currently available: osteoprotegerin, galectin-3, cystatin C, chromogranin A, and the adipokines adiponectin, leptin, and resistin. Despite the intriguing early information from these newer markers, none is ready for routine clinical use. Much additional study is needed to determine how these biomarkers will fit into diagnostic and treatment algorithms for patients who have heart failure.

机译：心力衰竭的病理生理学很复杂，代表不同病理生理学途径的生物标志物列表正在迅速增加。本文着眼于一些有前途的新型生物标志物，这些标志物有助于更好地了解与心力衰竭有关的病理生理机制，但目前尚无相关数据：骨保护素，半乳糖凝集素-3，胱抑素C，嗜铬粒蛋白A和脂联素脂联素，瘦素，和抵抗素。尽管这些更新的标记提供了令人感兴趣的早期信息，但尚无任何常规临床使用准备。需要进行大量其他研究来确定这些生物标记物如何适合心力衰竭患者的诊断和治疗算法。

著录项

来源
《Heart failure clinics》 |2009年第4期|共10页
作者
Gupta S; Drazner MH; de Lemos JA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. CardioPulse Articles * The 2012 ESC Guidelines on Heart Failure * Heart Failure Congress 2012 * Heart Failure Congress 2012 promotes integration of pharmacology and technology * Novel pharmacotherapies for heart failure * Heart failure: a vision for the future * Book review * Cardiac Biomarkers--Expert Advice for Clinicians * Level of education and heart failure. [J] . European Heart Journal: The Journal of the European Society of Cardiology . 2012,第14期

机译：CardioPulse文章* 2012 ESC心力衰竭指南* 2012心力衰竭会议* 2012心力衰竭会议促进药理学和技术的集成*心力衰竭的新型药物疗法*心力衰竭：对未来的展望*书评*心脏生物标志物-专家给临床医生的建议*教育水平和心力衰竭。
2. Kardiale Biomarker bei Myokardinfarkt und Herzinsuffizienz // Use of Cardiac Biomarkers for the Diagnosis of Myocardial Infarction and Heart Failure. [J] . Hillinger P, Mueller C, Puelacher C, Journal fuer Kardiologie: Oesterreichische Zeitschrift fuer Herz-Kreislauferkrankungen . 2015,第5a6期

机译：Myokardinfarkt和Herzinsuffizienz的Kardiale生物标志物// //心肌生物标志物在心肌梗塞和心力衰竭的诊断中的应用。
3. Evolving Use of Biomarkers in the Management of Heart Failure. [J] . Sara Paul, Karol Harshaw-Ellis Cardiology in review . 2019,第3期

机译：在心力衰竭管理中不断使用生物标志物。
4. CARDIAC BIOMARKERS MEASURED IN 500 CATS WITH HEART DISEASE, HEART FAILURE OTHER DISfiAS [C] . Stephen Ettinger, Andrew Beardow Canadian Veterinary Medical Association Convention . 2009

机译：心脏病，心脏病，心力衰竭和其他差异测量的心脏生物标志物。
5. Hearts in the Balance: The Impact of Desired Versus Received Social Support Needs on Persons with Heart Failure. [D] . Schrader, Melanie P. 2016

机译：心脏处于平衡状态：希望获得的社会支持对心力衰竭患者的影响。
6. Salivary Biomarkers for Diagnosis and Therapy Monitoring in Patients with Heart Failure. A Systematic Review [O] . Aidonis Rammos, Aris Bechlioulis, Petros Kalogeras, 2021

机译：心力衰竭患者诊断和治疗监测的唾液生物标志物。系统评价
7. Metabolomic Profiling Identifies Novel Circulating Biomarkers of Mitochondrial Dysfunction Differentially Elevated in Heart Failure With Preserved Versus Reduced Ejection Fraction: Evidence for Shared Metabolic Impairments in Clinical Heart Failure. [O] . Hunter, Wynn, Kelly, Jacob, McGarrah, Robert W. III, 2016

机译：代谢组学分析鉴定新的心肌线粒体功能障碍的循环生物标志物在心力衰竭中差异升高，保留与减少的射血分数：临床心力衰竭中共同代谢损伤的证据。
8. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. Clinical Practice Guideline No. 11; Heart Failure: Management of Patients with Left-Ventricular Systolic Dysfunction. Quick Reference Guide for Clinicians No. 11; Living with Heart Disease: Is It Heart Failure. Patient and Family Guide [R] . 1994

机译：心力衰竭：左心室收缩功能障碍患者的评估和护理。临床实践指南第11号;心力衰竭：左心室收缩功能障碍患者的治疗。临床医生快速参考指南第11号;与心脏病共存：是心衰吗？患者和家庭指南

Newer biomarkers in heart failure.

摘要

著录项

相似文献

相关主题

期刊订阅